Rosa DeLauro actually said...
Our share, U.S. share, of biomedical R&D expenditure declined from 52 percent to 42 percent despite what is happening in the rest of the world.
Context
DeLauro highlights the decline in U.S. biomedical R&D funding compared to global trends.
02/26/2014